semaglutide gastric intestinal obstruction class action in west virginia glp-1 gastrointestinal Safety and Tolerability of Glucagon-Like Peptide semaglutide gastric intestinal obstruction lawyer

Muscular weakness may be a sign of drug-induced hyperkalemia

Sergey Terushkin, MD, FACS Patients begin by scheduling a secure telehealth consultation to discuss peptide therapy goals and eligibility

While compounded medications are not FDA-approved as drugs, the compounding process itself is FDA-regulated

One could be forgiven for thinking of Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity and other glucagon-like peptide-1 receptor agonists (GLP-1s) as miracle drugs

2025;55:e302

By reducing glucagon, semaglutide helps to prevent unnecessary increases in blood sugar, especially during periods when a person is not eating